Potassium chloride 0.3% (potassium 20mmol/500ml) / Glucose 10% / Sodium chloride 0.9% solution for infusion 500ml bottles United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

potassium chloride 0.3% (potassium 20mmol/500ml) / glucose 10% / sodium chloride 0.9% solution for infusion 500ml bottles

potassium 20mmol/500ml) / glucose 10% / sodium chloride 0.9% solution for infusion 500ml bottles (special order - sodium chloride; potassium chloride; glucose monohydrate - solution for infusion - 9mg/1ml ; 3mg/1ml ; 100mg/1ml

DEXTROSE 4.3 % AND 0.18 % SODIUM CHLORIDE VIOSER SOLUTION FOR INFUSION Israel - English - Ministry of Health

dextrose 4.3 % and 0.18 % sodium chloride vioser solution for infusion

eldan electronic instruments co ltd, israel - dextrose anhydrous; sodium chloride - solution for infusion - dextrose anhydrous 4.3 %w/v; sodium chloride 0.18 %w/v - sodium chloride - dextrose 4.3 % and 0.18 % sodium chloride vioser solution is used in the following indications: dehydration treatment due to a moderated loss of sodium and chloride (vomiting, diarrhoea, renal disorders, over use ofdiuretics) in cases where a source of energy is required (particularly starvation). paediatric population: this product should only be used in paediatric specialist settings (such as renal, hepatic and cardiac units, high dependency units and intensive care units) for intravenous fluid therapy requiring the use of 0.18% sodium chloride and4% glucose to maintain fluid and electrolyte balance.

D-LYTE CO-PACK 2.7MG+0.52MG+0.58MG+0.30MG+20MG PER 200ML,6.75MG+1.30MG+1.45MG+0.75MG+20MG PER 500ML SACHET,13.5MG+2.60MG+2.90MG+ Uganda - English - National Drug Authority

d-lyte co-pack 2.7mg+0.52mg+0.58mg+0.30mg+20mg per 200ml,6.75mg+1.30mg+1.45mg+0.75mg+20mg per 500ml sachet,13.5mg+2.60mg+2.90mg+

gittoes pharmaceuticals limited; gittoes pharmaceuticals limited - anhydrous glucose+sodium chloride+trisodium citrate+potassium chloride/zinc,anhydrous glucose+sodium chloride+trisodium citrate+potassium chloride/zinc,anhydrous glucose+sodium chloride+trisodium citrate+potassium chloride/zinc - oral liquid ordinary combination pack powders/granules - 2.7mg+0.52mg+0.58mg+0.30mg+20mg per 200ml,6.75mg+1.30mg+1.45mg+0.75mg+20mg per 500ml sachet,13.5mg+2.60mg+2.90mg+1.50mg+20mg per

SODIUM CHLORIDE 0.45 % INJECTION Israel - English - Ministry of Health

sodium chloride 0.45 % injection

neopharm (israel) 1996 ltd - sodium chloride - solution for injection - sodium chloride 0.45 g / 100 ml - sodium chloride - sodium chloride - supply of water for administration of electrolytes. vehicle for therapeutic regimen.

Prismasol 2 mmol/l Potassium solution for haemofiltration and haemodialysis Malta - English - Medicines Authority

prismasol 2 mmol/l potassium solution for haemofiltration and haemodialysis

gambro lundia ab - magnesium chloride, hexahydrate, sodium chloride, sodium hydrogen, carbonate, lactic acid, calcium chloride, dihydrate, potassium chloride, glucose anhydrous - solution for haemofiltration - magnesium chloride hexahydrate 0.102 millimole(s)/litre ; sodium chloride 6.128 millimole(s)/litre ; sodium hydrogen carbonate 2.936 millimole(s)/litre ; lactic acid 0.27 millimole(s)/litre ; calcium chloride dihydrate 0.257 millimole(s)/litre ; potassium chloride 0.149 millimole(s)/litre ; glucose anhydrous 1.1 millimole(s)/litre - blood substitutes and perfusion solutions

Sodium Chloride 0.9% Malta - English - Medicines Authority

sodium chloride 0.9%

demo s.a. pharmaceutical industry 21st km national road athens - lamia 14568 krioneri, greece - sodium chloride - solution for injection - sodium chloride 9 mg/ml - blood substitutes and perfusion solutions

BAXTER 0.9% SODIUM CHLORIDE 9g/L injection BP bag AHB1324 Australia - English - Department of Health (Therapeutic Goods Administration)

baxter 0.9% sodium chloride 9g/l injection bp bag ahb1324

baxter healthcare pty ltd - sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections - indications as at 9 october 2002: sodium chloride (0.9%) intravenous infusion is indicated for extracellular fluid replacement and in the management of metabolic alkalosis in the presence of fluid loss, and for restoring or maintaining the concentration of sodium and chloride ions.

Sodium Chloride New Zealand - English - Medsafe (Medicines Safety Authority)

sodium chloride

baxter healthcare ltd - sodium chloride 0.9% - solution for infusion - 0.9 % - active: sodium chloride 0.9% - sodium chloride (0.9%) intravenous infusion is indicated for extracellular fluid replacement and in the management of metabolic alkalosis in the presence of fluid loss, and for restoring or maintaining the concentration of sodium and chloride ions.